Article Text
Abstract
Objective To perform a systematic review and meta-analysis identifying (1) potential modifiable risk factors and (2) associated modifiable factors for patellar tendinopathy in athletes.
Design A systematic review and meta-analysis was conducted. Risk of bias was assessed using the Newcastle-Ottawa Scale and grouped based on study design. Meta-analytic statistics were performed for items reported by five or more studies. A strength of evidence rating is provided for items not appropriate for meta-analysis.
Data sources PubMed, Web of Science, Scopus and Cinahl were searched on 14 November 2017.
Eligibility criteria Quantitative, original research reporting potential modifiable risk factors or associated factors, comparing athletes with patellar tendinopathy with a group without the injury.
Results 862 records were screened and 31 articles were included (6 prospective, 25 cross-sectional). There was a lack of strong evidence for any potential modifiable risk factor or associated factors. There was limited or conflicting evidence that decreased ankle dorsiflexion range of motion, decreased posterior thigh and quadriceps flexibility, greater volume of jump training, more volleyball sets played per week, greater countermovement jump (CMJ) height and greater activity volume are potential modifiable risk factors. Meta-analysis supported greater activity volume (Cohen’s d=0.22, 95% CI 0.06 to 0.39, p=0.008), higher body weight (0.36, 0.17 to 0.55, p<0.001) and greater CMJ height (0.31, 0.07 to 0.56, p=0.01) as associated modifiable factors.
Conclusions There is a lack of strong evidence for any potential modifiable risk factors or associated factors. Factors with lower levels of support may be of interest in designing prevention programmes but require further research in high-quality, prospective studies.
- injury prevention
- sports rehabilitation programs
- training load
- tendon
- tendinopathy
Statistics from Altmetric.com
Introduction
Patellar tendinopathy is a clinical diagnosis characterised by focal pain at the inferior pole of the patella and load-dependent symptoms, with increased loads resulting in a greater degree of pain.1 It most commonly affects athletes participating in jumping sports, where the extensor mechanism experiences high, repetitive loads.2 The prevalence of patellar tendinopathy is high, with 11.8%–14.4% of recreational volleyball and basketball players reporting symptoms.3 In elite players the prevalence is even higher, with 32% of elite men’s basketball players and 45% of elite men’s volleyball players experiencing symptoms.2 These players have decreased sports performance2 and prolonged absences from training and matches.4 Although many athletes with patellar tendinopathy will seek treatment or modify activity, 49% will experience recurrent symptoms4 and more than 50% may retire from sports participation due to persistent pain.5 Therefore, it is of interest to identify ways to prevent patellar tendinopathy so athletes never enter a cycle of recurrent pain and functional limitation.
Identification of risk factors for patellar tendinopathy is essential to the development of targeted prevention programmes. A previous systematic review by van der Worp et al 6 identified over 40 potential risk factors for patellar tendinopathy. However, the authors found that many proposed risk factors have not been prospectively investigated, have limited support from low-quality studies or have conflicting evidence. Additionally, not all risk factors were modifiable. Thus, they may assist in identifying athletes at higher risk of injury but do not provide an opportunity for clinicians to intervene to reduce that risk. Building on the work by van der Worp et al,6 the purpose of this study was twofold:
To systematically identify potential modifiable risk factors for patellar tendinopathy in athletes using prospective, longitudinal studies.
To systematically identify associated modifiable factors in athletes, which lack prospective support as potential modifiable risk factors, using cross-sectional studies.
Methods
The protocol for this review was registered on the International Prospective Register of Systematic Reviews (PROSPERO) (ID #42016052904) and conducted according to the Preferred Reporting Items for Systemic Reviews and Meta-Analysis guidelines.7
Search strategy
Using the assistance of a research librarian, a search strategy was developed based on two categories of interest: (1) terms related to patellar tendon or patellar tendinopathy and (2) terms related to modifiable risk factors (online supplementary material). A human participants restriction was applied. Studies were not limited to a specific time period or language. Preliminary searches were conducted to ensure that the search strategy was comprehensive. Following preliminary searches, articles including the terms ‘ACL’, ‘anterior cruciate ligament’, ‘graft’, ‘arthroplasty’, ‘prosthetic’ and ‘fracture’ in their title or abstract were excluded to limit the number of irrelevant articles. An online search was performed of PubMed, Web of Science, Scopus and Cinahl. The initial search was conducted on 18 November 2016 and repeated on 14 November 2017. Following the full-text review phase, references of included studies and retained systematic reviews were hand-searched for additional relevant articles not captured by the initial search.
Supplemental material
Inclusion and exclusion criteria
All quantitative original research comparing athletes with patellar tendinopathy with a control group without the injury were considered. Patellar tendinopathy is defined as symptoms isolated to the inferior pole of the patella.1 However, historically, patellar tendinopathy was more broadly defined as ‘Jumper’s Knee’ and included symptoms anywhere along the patellar tendon or quadriceps tendon.8 Therefore, studies that used a broader definition of patellar tendinopathy were included, as symptoms at sites other than the inferior pole of the patella are less common.8 Studies in which diagnosis was based on imaging alone were excluded since patellar tendon structural changes are common in individuals without clinical signs and symptoms of patellar tendinopathy.9 Animal, cadaveric or interventional studies were excluded. Abstracts, conference proceeding, editorials, opinion-based papers, reviews (narrative or systematic), letters, case series and case studies were also excluded. However, systematic reviews were retained until the full-text phase so their references could be included in the hand-search. Additionally, studies lacking modifiable potential risk factors or associated factors, or a clear comparison between patellar tendinopathy and a group without the injury, were excluded.
Study selection
Prior to record screening, duplicates were removed by the research librarian. Two reviewers (ALS and AH-S) completed title, abstract and full-text review independently for all records. Records were screened for inclusion/exclusion criteria. After each phase of the screening process, disagreements regarding record inclusion were discussed, and a third reviewer (KGS) was consulted if consensus could not be reached. Included articles were grouped based on study design: prospective, longitudinal, cohort studies (prospective), and cross-sectional or case–control studies (cross-sectional). Prospective studies can identify potential modifiable risk factors, since presence or exposure to the risk factor is determined prior to the development of patellar tendinopathy. At best, items identified in cross-sectional studies can only be considered associated modifiable factors, since a temporal relationship cannot be established.
Quality assessment
Studies were independently assessed for risk of bias and methodological quality by two reviewers (ALS and PK) using a modified version of the Newcastle-Ottawa Scale (NOS).10 The NOS is an eight-item checklist grouped into three domains (selection, comparability and outcome or exposure) designed to assess risk of bias in non-randomised studies. The instrument has two versions: one for case–control (cross-sectional) studies and one for cohort (prospective) studies. For each item assessed, a list of responses is provided and the reviewer must select the response most appropriate for the study. Responses that indicate low risk of bias are awarded a star and studies can receive a maximum score of nine stars. For certain items, multiple responses may be appropriate. For example, studies that reported multiple factors of interest may have used independent blind assessment for some factors and self-report for others. In these instances, separate scores are reported. The NOS has been previously used for quality assessment in systematic reviews11 12 and was deemed appropriate for use in a review of quality assessment instruments.13 If reviewers disagreed on a quality assessment rating, the inconsistency was discussed and a third reviewer (KGS) was consulted, if necessary, to resolve disputes. Studies were not excluded based on their quality assessment score. However, the quality assessment score was considered for determining the strength of the results.
Data extraction
Data extraction was completed by a single reviewer (ALS) using predefined categories and independently verified by a second reviewer (PK). These categories included study design, potential risk factors investigated, inclusion and exclusion criteria, group allocation, sample size, population age, sports included, competition level, sex distribution, proportion of cases and controls, diagnostic criteria for patellar tendinopathy, and study conclusions. For each factor of interest, the method of measurement, reported values, statistical test used and significance level were also recorded. Factors were excluded from analysis if they were used for matching case and control groups, as the distribution of these factors was controlled by the research team and cannot be attributed to the injury. Additionally, factors previously reported in a study using the same or part of the same sample were excluded to prevent data duplication. Ultrasound imaging measures and biomechanical variables were not extracted since these measures were recently explored in other systematic reviews.14 15 Potential risk factors or factors associated with patellar tendinopathy were categorised into six groups:
Anthropometrics.
Joint range of motion and muscle length.
Sports and physical activity.
Functional test performance.
Muscle performance.
Occupational demands.
Data synthesis and analysis
Cohen’s kappa values were calculated for inter-rater agreement for each stage of the screening process and for quality assessment ratings.16 Scores were interpreted using predefined cut-off scores.17
For potential risk factors or associated factors reported by five or more studies within a study-design grouping, meta-analytic statistics are reported. Cohen’s d with 95% CI was calculated for each factor using the Comprehensive Meta-Analysis V.3.3.070 software (Englewood, New Jersey, USA) with the alpha set at 0.05.18 A positive effect indicates that the measured value was larger in the patellar tendinopathy group and a negative effect indicates the value was smaller in the patellar tendinopathy group. As a follow-up, ORs (OR=((n) exposed cases/(n) unexposed cases)/((n) exposed controls/ (n) unexposed controls)) with 95% CIs are reported for significant effects.19 For calculation of effect sizes the fixed-effects model was used when heterogeneity between studies was low or moderate and random-effects model used when it was high. This study followed McAuliffe et al’s14 criteria for assessing heterogeneity using Higgins’ I2 value20; an I2 ≤30% was considered low and I2 >30% was moderate, and heterogeneity was high when I2 >50%.
Funnel plots21 were created and analysed for publication bias using Duval and Tweedie’s trim and fill method for all factors reported in the quantitative synthesis.22 If a factor of interest was reported separately for unilateral and bilateral tendinopathy, sex, or limb, then the weighted pooled mean and variance were used in the analysis. In some studies, several measures of the same outcome were reported. In these cases, the weighted pooled mean and variance were also used to obtain a combined measure of effect. If a factor was discussed but insufficient data were reported to calculate a measure of effect, then the authors were contacted to request additional information.
Studies or factors not included in the meta-analysis were included in the qualitative summary. The strength of evidence for factors of interest was assessed using the criteria established by Mallows et al 11 to synthesise non-randomised studies. Each study was assigned a quality assessment score by dividing the stars awarded on the NOS by the number of available stars. Based on these scores, studies were classified as low (0.00–0.44, 1–4 stars), moderate (0.45–0.70, 5 or 6 stars) or high quality (0.71–1.00, 7–9 stars).11 A rating system, adapted by Mallows et al 11 from the Cochrane Collaboration Back Review Group,23 was used to rate the level of evidence for each factor of interest, accounting for the quality and quantity of evidence (table 1). A study was considered to have positive findings if significance testing was performed and the p value was less than 0.05.
Results
Identification of studies
The initial search resulted in 862 studies (figure 1). After removal of duplicates, 768 records were screened for inclusion and exclusion criteria. Following title and abstract review, 133 studies were appropriate for full-text review. One hundred and seven studies were excluded during full-text review, yielding 26 articles for inclusion. Inter-rater agreement ranged from moderate to almost perfect (online supplementary material). Five additional articles were included after hand-searching references of included articles and retained systematic reviews, resulting in 31 included articles for qualitative review (figure 1). Of these articles, 28 contained factors that were included in the quantitative synthesis (figure 1). All included articles were in English. Authors provided additional information for five of eight articles for which additional information was requested.
Study characteristics
Of the 31 studies considered, 6 were prospective. All six included young athletes, with mean ages under 30. The majority (83%, 5/6) played either volleyball or basketball, and consisted of elite athletes competing at the professional, national or international level (67%, 4/6) (online supplementary material). Twenty-five studies were cross-sectional, and similarly 88% (22/25) had mean ages less than 30 years old. The majority of athletes were volleyball and basketball players (80%, 20/25); however, only 32% (8/25) included elite athletes (online supplementary material). The majority of prospective (86%, 6/7) and cross-sectional (56%, 14/25) studies included both sexes, although 40% (10/25) of cross-sectional studies consisted of only male athletes (online supplementary material).
Risk-of-bias assessment
Prospective studies and cross-sectional studies each had a median NOS score of 5 out of 9 points, but there was greater variability in scores for cross-sectional studies (range: 1–8 points) than prospective studies (range: 4–6 points) (table 2). All prospective studies used appropriate selection of a non-exposed cohort (item 2) and had adequate follow-up (item 7). One prospective study used independent blind assessment or medical record linkage to determine the presence of patellar tendinopathy (item 6). All cross-sectional studies used the same method to determine the presence of factors of interest for cases and controls (item 7) and 23 (92%) used community controls (item 3). Two cross-sectional studies used secure records or a blinded exam to determine the presence of a factor of interest (item 6). Inter-rater agreement was almost perfect (online supplementary material). On visual inspection, using the trim and fill method, there did not appear to be evidence of publication bias for body mass index (BMI), body weight or activity volume for cross-sectional studies (online supplementary material). Other items had too few studies to draw conclusions about publication bias.
Prospective studies: potential risk factors
Quantitative synthesis: meta-analysis
Anthropometrics
Body weight was the only prospectively investigated factor appropriate for meta-analysis. Five studies24–28 with high heterogeneity (I2=55.7) were included. Body weight was not significantly associated with risk of patellar tendinopathy (p=0.08) (online supplementary material).
Qualitative synthesis
Joint range of motion and muscle length
Limited evidence from individual moderate-quality studies supported decreased ankle dorsiflexion range of motion,25 posterior thigh flexibility28 and quadriceps flexibility28 as potential risk factors (table 3).
Sports and activity-related factors
Limited evidence from one moderate-quality study supported greater volume of jump training and greater number of volleyball sets played per week as potential risk factors.29 There was conflicting evidence from four moderate-quality to low-quality studies for increased activity volume as a potential risk factor (table 3).24–27
Cross-sectional studies: associated modifiable factors
Quantitative synthesis: meta-analysis
Anthropometrics
BMI and body weight were appropriate for meta-analysis. For BMI, nine studies with high heterogeneity (I2=71.7) were included in the meta-analysis (online supplementary material).3 30–37 BMI was not significantly associated with patellar tendinopathy (p=0.06) (online supplementary material). One low-quality study3 was excluded from the meta-analysis due to insufficient data, but the reported results were in agreement with the quantitative synthesis. For body weight, 13 studies with high heterogeneity (I2=77.8) were included in the meta-analysis (figure 2).2 3 30 35 37–44 There was a small, positive effect for body weight, indicating that greater body weight is significantly associated with patellar tendinopathy (figure 2). This effect translates to an OR of 1.92 (95% CI 1.35 to 2.73). One low-quality study was excluded due to insufficient data.45 In this study, weight did not differ significantly between young elite soccer players with or without patellar tendinopathy.
Sport and activity-related factors
Activity volume was appropriate for meta-analysis. Ten studies with high heterogeneity (I2=67.0) were included (figure 2).2 3 8 30 32 35 39 42 44 46 There was a small, positive effect for activity volume, indicating that greater activity volume is significantly associated with patellar tendinopathy (figure 2). This effect translates to an OR of 1.50 (95% CI 1.11 to 2.02). Two low-quality studies and one high-quality study were excluded due to insufficient data. These studies did not find a significant association between hours of weekly sports participation3 or training31 45 and patellar tendinopathy.
Functional testing
CMJ height was appropriate for meta-analysis. CMJ height included performance on the CMJ, drop CMJ and vertical jump, as these measures allow a countermovement and assess an athlete’s ability to use the stretch-shortening cycle.47 Five studies with moderate heterogeneity (I2=44.2) were included (figure 2).42 46 48–50 There was a small, positive effect for CMJ height, indicating that greater CMJ height is associated with patellar tendinopathy (figure 2). This effect translates to an OR of 1.77 (95% CI 1.13 to 2.77).
Muscle performance
Knee extension torque production was appropriate for meta-analysis. Five studies with high heterogeneity (I2=89.7) were included (online supplementary material).33 40 41 44 51 Knee extension torque production was not significantly associated with patellar tendinopathy (p=0.19) (online supplementary material).
Qualitative synthesis
Joint range of motion and muscle length
There was conflicting evidence from three moderate-quality to low-quality studies for decreased ankle dorsiflexion range of motion and altered posterior thigh flexibility as associated modifiable factors (table 4).30 44 46
Sport and activity-related factors
Moderate evidence from one high and one moderate-quality study supported greater volume of strength training per week as an associated modifiable factor (table 4).2 42 Limited evidence from one low-quality study supported slower average running pace as an associated modifiable factor (table 4).51 There was conflicting evidence from one high and one moderate-quality study for greater volume of jump training per week as associated modifiable factors (table 4).2 42
Functional testing
Limited evidence from one moderate-quality study supported greater average force and power with a 0.5-body weight or 1-body weight load during a standing jump, greater work performed during a drop CMJ and better performance on a jump test battery as associated modifiable factors (table 4).42 There was conflicting evidence from one high-quality and one moderate-quality study for greater standing jump height with a 20 kg load, work performed during a standing jump or CMJ, difference between CMJ and standing jump height, and average power on 15 s rebound test as associated modifiable factors (table 4).42 48
Muscle performance
Moderate evidence from one high-quality study supported a steeper slope for the motor evoked potential curve of the quadriceps, representing altered corticospinal excitability to the quadriceps, as an associated modifiable factor (table 4).33 Limited evidence from individual low-quality studies supported decreased knee extension fatigue ratio40 and normalised peak hip extension torque44 as associated modifiable factors (table 4).
Discussion
Main findings
There is a lack of strong evidence for any prospectively investigated potential modifiable risk factors for patellar tendinopathy. However, there was limited or conflicting evidence that decreased ankle dorsiflexion range of motion, decreased posterior thigh and quadriceps flexibility, greater volume of jump training, more volleyball sets played per week, greater CMJ height and greater activity volume are potential modifiable risk factors for patellar tendinopathy. Additionally, there was a lack of strong evidence for any associated modifiable factor reported in cross-sectional studies. Moderate to conflicting evidence supported greater volume of strength training, better jumping performance, less normalised hip extension torque, decreased knee extension fatigue ratio and altered corticospinal excitability to the quadriceps as associated modifiable factors.
Risk of bias and study quality
In agreement with the findings of van der Worp et al,6 there were few prospective studies investigating risks factors and none were of high quality. Many of the cross-sectional studies were of low quality, and nearly half failed to control for covariates, which limits the strength of evidence for associated modifiable factors. However, there was no evidence of publication bias in the meta-analysis of BMI, body weight or activity volume in cross-sectional studies. In light of these findings, additional high-quality, prospective studies are needed.
Anthropometric measures
A systematic review by Gaida et al 53 found that adiposity, including the surrogate measures of BMI and body weight, is frequently associated with tendinopathy and may be a risk factor for tendon injuries. In contrast, this study found no evidence supporting anthropometric measures as potential risk factors for patellar tendinopathy. Although a small, positive effect was found for body weight in cross-sectional studies, suggesting that greater body weight is an associated modifiable factor, body weight was not significantly associated with an increased risk of patellar tendinopathy in prospective studies. Patellar tendinopathy is most common in young athletic individuals,3 and the majority of studies included in this review were conducted in elite athletes. Therefore, it is unlikely that the athletes in these studies had high adiposity. Instead, higher body weight likely reflects a taller stature and a build that is more muscular.54
Joint range of motion and muscle length
Individual moderate-quality prospective studies identified decreased ankle dorsiflexion range of motion, posterior thigh flexibility and quadriceps flexibility as potential risk factors for patellar tendinopathy. In one prospective and one cross-sectional study, athletes had a higher risk of patellar tendinopathy if their dorsiflexion range of motion fell below cut-off scores of 36.5°25 or 45.0°,46 respectively. When jumping, adequate ankle joint range of motion is of importance since the ankle is responsible for absorbing 37%–50% of the total kinetic energy during the landing phase.55 Additionally, decreased dorsiflexion is moderately correlated with higher ground reaction forces during a drop landing task.56 This increase in ground reaction force, coupled with potentially altered ability to absorb kinetic energy at the ankle, may increase patellar tendon loads. Furthermore, decreased ankle weight-bearing dorsiflexion range of motion results in altered knee kinematics during squatting,57 which may increase patellar tendon loads during athletic activities.15 It is hypothesised that decreased posterior thigh flexibility may contribute to patellar tendon overload by decreasing the mechanical advantage of the extensor mechanism and increasing the demands placed on the quadriceps during knee extension.44 Similarly, decreased quadriceps flexibility may contribute to overload by increasing passive tension within the patellar tendon.37 Based on the limited evidence, clinicians may want to assess for restrictions in these measures, but further research using high-quality, prospective study designs is warranted.
Sport and activity-related factors
Patellar tendinopathy is considered an overuse injury so an association between higher levels of activity or training and injury is expected.58 Therefore, the limited or conflicting evidence from prospective studies regarding volume of activity or jump training and the small effect from cross-sectional studies for activity volume is surprising. This may be explained in part by the composition of the studies and how activity was defined. The plurality of studies consisted of elite athletes so the participants are likely completing a high volume of training and there is minimal variability between groups. Additionally, activity was typically reported as a duration, with no indication of the intensity, type of activity or whether activity level had changed. Activity duration alone may not accurately describe the load placed on the patellar tendon or the tendon’s readiness to accommodate those loads. Thus, future studies should examine patellar tendon load during activity and the relationship between current and previous level of activity to provide a more complete picture of how activity contributes to patellar tendinopathy. Although there was no evidence from the sole prospective study investigating weekly strength training volume, there was moderate evidence from two cross-sectional studies that greater weekly strength training volume may be an associated modifiable factor. In designing prevention or rehabilitation programmes, clinicians may want to consider altering the volume of activity, jump or strength training to reduce cumulative tendon load. Additionally, other parameters, such as intensity, activity type and prior activity level, and their relationship to recovery should be considered.
Functional testing
Although greater CMJ height is the only measures with prospective support, limited or conflicting evidence identified higher values on other metrics of jump performance as associated modifiable factors. This suggests that athletes with greater jumping ability are at higher risk of developing patellar tendinopathy. With greater jumping ability, athletes are likely generating greater forces at take-off59 and must dissipate greater vertical ground reaction forces at landing.60 As a result, they experience a higher cumulative load on the extensor apparatus for a given jump. These athletes may also be completing a higher quantity or frequency of jumps since they likely have more opportunities to play and are more involved while on the court. A recent systematic review of the relationship between jump biomechanics and patellar tendinopathy identified a ‘stiff’ landing pattern as a potential risk factor for patellar tendinopathy.15 The authors also emphasised that adequate lower extremity flexibility and range of motion are necessary to use a more flexible landing pattern, which may be protective against patellar tendinopathy. Since better jumping ability is desirable in an athletic population, clinicians should consider modifying landing biomechanics and lower extremity flexibility and range of motion instead to reduce the risk of injury.
Muscle performance
There was no evidence from prospective studies or a meta-analysis of cross-sectional studies that knee extension torque production was associated with patellar tendinopathy. However, there was moderate to limited evidence from individual cross-sectional study that altered corticospinal excitability to the quadriceps and decreased knee extension fatigue ratio may be an associated modifiable factor. This suggests that quadriceps muscle performance may be altered in patellar tendinopathy, but this alteration may not be captured by torque production alone. Participation in jumping sports requires rapid force development, high levels of lower extremity power and multijoint coordination.61 Additionally, these muscle performance tests are typically performed in a rested state and do not assess how these measures may change with fatigue. It should be noted that knee extension torque was the only muscle performance measure relating to the quadriceps that was prospectively investigated. Thus, further research is warranted to determine if other measures of quadriceps muscle performance, such as fatigue resistance, endurance, power and muscle activation, are related to the development of patellar tendinopathy.
There was also limited evidence supporting decreased normalised hip extension torque as an associated modifiable factor. During landing tasks, the hip extensors are responsible for dissipating 20%–25% of the kinetic energy absorbed by the lower extremities.55 Therefore, decreased hip extensor strength may increase demands placed on the knee extensors. Furthermore, the contribution of the hip extensors to energy dissipation increases when using a softer landing strategy.55 62 To compensate for decreased hip extension strength, individuals may adopt a stiffer landing strategy, which has been previously identified as a potential risk factor for patellar tendinopathy.15 Clinicians may want to assess for hip extension strength deficits in prevention programmes, although prospective studies are needed to confirm if this deficit is a risk factor for patellar tendinopathy.
Occupational demands
There was no prospective evidence that occupational classification (eg, heavy vs light physically demanding work) is a potential risk factor for patellar tendinopathy. However, there was limited evidence from one cross-sectional study that heavy physically demanding work may be an associated modifiable factor. Given the limited evidence and lack of prospective support, it is unlikely that occupational classification is a risk factor for patellar tendinopathy.
Patellar tendinopathy and tendon load
Patellar tendinopathy is considered an overuse injury resulting from repetitive stress to the patellar tendon with insufficient recovery.63 This is supported by the findings of this systematic review and meta-analysis, as each of the potential modifiable risk factors with support from prospective studies may directly or indirectly increase the loads placed on the patellar tendon. However, some of these risk factors, such as jumping ability, may be beneficial to athletic performance and undesirable to change. Therefore, clinicians may need to manipulate other training parameters to reduce the cumulative load on the tendon or increase recovery time between activities.
Limitations
There were several limitations to our review. First, different versions of the NOS were used for prospective and cross-sectional studies. Therefore, quality assessment ratings are not comparable between study designs. Although certain cross-sectional studies scored higher than prospective studies, the cross-sectional studies are not able to establish a temporal relationship between the factor of interest and patellar tendinopathy. Second, included studies encompassed a variety of populations, methods and research questions, which is reflected in the high heterogeneity between studies. A consequence of high heterogeneity is that the calculated effect may be due to the differences in study design or populations evaluated, not true differences in the outcome of interest.20 To address this limitation, a random-effects model was used when heterogeneity was high, as this provides a more conservative estimate of the effect size. Third, many potential risk factors or associated factors were investigated by a limited number of studies, and many of these, especially for cross-sectional studies, had small sample sizes. This limits the strength of evidence for these items, and lack of support does not indicate that an item of interest is definitely not associated with patellar tendinopathy. Therefore, clinicians should use their clinical judgement and not completely disregard other potential risk factors when creating an individualised prevention programme. Fourth, a large portion of these studies were conducted in male, elite athletes. Although this is representative of the population most commonly diagnosed with patellar tendinopathy, it may limit generalisability to female and recreational athletes. Finally, there was large variability between definitions of patellar tendinopathy, which was expected, as the definition of patellar tendinopathy has shifted over time. However, this potentially introduces bias by incorporating individuals with other diagnosis. Despite this concern, the decision was made to include broader definitions of patellar tendinopathy, as the prevalence of other diagnosis is typically low compared with true patellar tendinopathy, and we did not want to exclude a large body of previous research.8
Conclusions
There was limited or conflicting evidence that decreased ankle dorsiflexion range of motion, decreased posterior thigh and quadriceps flexibility, greater volume of jump training, more volleyball sets played per week, greater CMJ height, and greater activity volume are potential modifiable risk factors for patellar tendinopathy. However, this evidence is based on few moderate-quality or low-quality prospective studies.
What is already known on this topic?
Patellar tendinopathy is extremely common in athletes who participate in jumping sports, and many will experience recurrent symptoms after treatment.
The symptoms of patellar tendinopathy are load-dependent, with increased loads resulting in a greater degree of pain.
Numerous risk factors have been proposed for patellar tendinopathy, but not all are modifiable.
What are the findings?
There was limited or conflicting evidence that decreased ankle dorsiflexion range of motion, decreased posterior thigh and quadriceps flexibility, greater volume of jump training, more volleyball sets played per week, greater CMJ height, and greater activity volume are potential modifiable risk factors for patellar tendinopathy.
Moderate to conflicting evidence supported greater volume of strength training, better jumping performance, less normalised hip extension torque, decreased knee extension fatigue ratio and altered corticospinal excitability to the quadriceps as associated modifiable factors.
There is a lack of strong evidence for any potential modifiable risk factors or associated modifiable factors for patellar tendinopathy, highlighting the need for high-quality, prospective studies of risk factors for patellar tendinopathy.
Acknowledgments
The authors would like to express their gratitude to Sarah Katz for her assistance in designing the search strategy, Barbara Wondrasch for her assistance in translating the articles during the screening process and the authors who were able to provide additional information about their studies.
References
Footnotes
Contributors ALS, AHS and KGS were responsible for the concept and design of this study, as well as the article screening process. ALS and PK conducted the quality assessment and data extraction. RTP provided statistical expertise. All authors assisted with interpretation of the results and revision of the manuscript.
Funding The research was funded in part by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institute of Health (#T32HD007490-18) and by a Florence P Kendall Doctoral Scholarship and a Promotion of Doctoral Studies I Scholarship from the Foundation for Physical Therapy.
Competing interests None declared.
Patient consent Not required.
Provenance and peer review Not commissioned; externally peer reviewed.